Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Mycoplasma ovipneumoniae multi-epitope fusion antigen MO-meAg5 and preparing method and application thereof

A Mycoplasma pneumoniae, mo-meag5 technology, applied in biochemical equipment and methods, bacterial antigen components, chemical instruments and methods, etc., can solve the problems that restrict the development of new vaccines for Mycoplasma ovis pneumonia and the complex antigen structure

Inactive Publication Date: 2016-08-17
SHIHEZI UNIVERSITY
View PDF4 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Due to the complex antigen structure of MO, no antigen with good immune protection has been screened and identified at home and abroad, which seriously restricts the development of new vaccines against Mycoplasma ovis pneumonia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Mycoplasma ovipneumoniae multi-epitope fusion antigen MO-meAg5 and preparing method and application thereof
  • Mycoplasma ovipneumoniae multi-epitope fusion antigen MO-meAg5 and preparing method and application thereof
  • Mycoplasma ovipneumoniae multi-epitope fusion antigen MO-meAg5 and preparing method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0070] 1. Extraction of MO genome

[0071] A purified strain of pure bacteria was transferred to 30-50ml containing 15-20% heat-inactivated premium horse serum (Biotopped, China) (v / v), 0.004-0.06% phenol red (Sigma, USA) (w / v), 25~30μg / ml ampicillin (OMEGA, USA) in the brain heart infusion broth medium (BD, USA), at 36~38℃, the concentration is 5% CO 2 Cultivate in the incubator for 5-8 days, when the growth titer reaches 10 9 CCU / ml, centrifuge at 12000r / min for 15min, collect the bacteria, discard the supernatant, and then use the Mycoplasma gDNA Mini Kit (BIOMIGA, USA) extraction kit to extract the total DNA of Mycoplasma ovis pneumoniae.

[0072]2. Construction of MO genome expression library

[0073] Use Sau3A I enzyme (TaKaRa, Japan) to digest the total DNA of MO, and master the optimal amount and time of enzyme digestion through the enzyme digestion pre-experiment, so that the genome fragments digested by the enzyme are concentrated in 0.5 ~ 3kb, and then according ...

Embodiment 2

[0100] 1. Extraction of MO genome

[0101] Transfer the purified strain to 30-50ml culture medium, and incubate at 36-38°C with a concentration of 4-6% CO 2 Cultivate in the incubator for 5-9 days, when the growth titer reaches 10 9 CCU / ml and above, centrifuge at 10000-16000r / min for 10-20min, collect the bacteria, discard the supernatant, and then use the Mycoplasma gDNA Mini Kit (BIOMIGA, USA) extraction kit to extract the total DNA of Mycoplasma ovis pneumoniae.

[0102] The medium is Brain Heart Infusion Broth Medium (BD, USA).

[0103] The preferred composition of the culture medium is as follows: containing

[0104] Heat-inactivated premium horse serum (Biotopped, China) 15-20% (v / v),

[0105] Phenol red (Sigma, USA) 0.004~0.06% (w / v),

[0106] Ampicillin (OMEGA, USA) 25-30 μg / ml.

[0107] 2. Construction of MO genome expression library

[0108] Use Sau3A I enzyme (TaKaRa, Japan) to digest the total MO DNA, so that the digested genome fragments are concentrated in...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a mycoplasma ovipneumoniae multi-epitope fusion antigen MO-meAg5 and a preparing method and application thereof. Antigen protein high in immunogenicity namely the mycoplasma ovipneumoniae multi-epitope fusion antigen MO-meAg5 can be obtained by extracting an MO genome, constructing and screening an expression library, constructing the MO multi-epitope fusion antigen and expressing the multi-epitope fusion antigen in escherichia coli, and a foundation is laid for further researching and developing a safe and efficient mycoplasma ovipneumoniae multi-epitope protein vaccine.

Description

technical field [0001] The invention relates to an ovine mycoplasma pneumoniae multi-epitope fusion antigen MO-meAg5 and a preparation method and application thereof, belonging to the field of biotechnology. Background technique [0002] In recent years, there have been reports of the occurrence and prevalence of Mycoplasma ovis pneumonia in Xinjiang, Gansu, Inner Mongolia, Qinghai, Shaanxi, Ningxia, Liaoning, Jiangsu, Sichuan, Yunnan and other provinces with developed sheep farming industry. With the healthy development of the sheep raising industry, the harm is increasing day by day, causing huge economic losses to the local sheep raising industry. [0003] Mycoplasma ovipneumoniae (Mycoplasma ovipneumoniae, MO) belongs to Mollusca class, Mycoplasma order, Mycoplasma family, a kind of Mycoplasma genus. [0004] MO is a minimal prokaryotic microorganism that lacks cell walls, is highly pleomorphic, and can pass through bacteria filters. The MO genome is smaller than most ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K14/30C12N15/70C40B50/06A61K39/02A61P31/04
CPCA61K39/0241C07K14/30C12N15/70C12N2800/101C12N2800/22C40B50/06
Inventor 乔军陈诚孟庆玲胡政香马玉田路路卢海亭曹旭东陈创夫
Owner SHIHEZI UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com